4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report)’s share price traded down 3.3% during mid-day trading on Thursday . The company traded as low as $17.70 and last traded at $17.75. 43,290 shares traded hands during trading, a decline of 91% from the average session volume of 498,062 shares. The stock had previously closed at […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s share price dropped 5.2% during trading on Wednesday . The stock traded as low as $21.99 and last traded at $22.06. Approximately 128,644 shares were traded during trading, a decline of 73% from the average daily volume of 480,035 shares. The stock had previously closed at $23.26. […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) insider Scott Bizily sold 3,750 shares of the business’s stock in a transaction dated Thursday, June 8th. The shares were sold at an average price of $20.85, for a total transaction of $78,187.50. Following the transaction, the insider now owns 1,737 shares in the company, valued at […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s stock price dropped 5.2% during trading on Wednesday . The stock traded as low as $21.99 and last traded at $22.06. Approximately 128,644 shares were traded during trading, a decline of 73% from the average daily volume of 480,035 shares. The stock had previously closed at $23.26. […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) shares traded up 7.5% on Friday after Bank of America raised their price target on the stock from $28.00 to $33.00. The stock traded as high as $21.29 and last traded at $20.99. 73,528 shares were traded during trading, a decline of 85% from the average session […]